These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 393438)
1. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Vergani GM; Vergani D; Jenkins PJ; Portmann B; Mowat AP; Eddleston AL; Williams R Clin Exp Immunol; 1979 Oct; 38(1):16-21. PubMed ID: 393438 [TBL] [Abstract][Full Text] [Related]
2. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941 [TBL] [Abstract][Full Text] [Related]
3. Direct and serum-induced lymphocytotoxicity against rabbit hepatocytes in chronic active hepatitis. Ortona L; Laghi V; Cauda R; Nervo P Boll Ist Sieroter Milan; 1981; 60(1):46-51. PubMed ID: 7272012 [TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH). Warnatz H; Rösch W; Gerlich W; Gutmann W Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882 [TBL] [Abstract][Full Text] [Related]
5. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis. Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716 [TBL] [Abstract][Full Text] [Related]
6. In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis. Mondelli M; Alberti A; Tremolada F; Williams R; Eddleston AL; Realdi G Clin Exp Immunol; 1986 Jan; 63(1):147-55. PubMed ID: 3082546 [TBL] [Abstract][Full Text] [Related]
7. Cell-mediated cytotoxicity to autologous hepatocytes in HBsAg positive liver disease: an analysis of the killing specificity and of the clinical use of the test. Actis GC; Touscoz GA; Crivelli O; Rizzetto M; Rocca B; Poli G; Verme G Boll Ist Sieroter Milan; 1984 Mar; 63(1):19-29. PubMed ID: 6206876 [TBL] [Abstract][Full Text] [Related]
8. Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers. Alexander GJ; Mondelli M; Naumov NV; Nouriaria KT; Vergani D; Lowe D; Eddleston AL; Williams R Clin Exp Immunol; 1986 Mar; 63(3):498-507. PubMed ID: 2940037 [TBL] [Abstract][Full Text] [Related]
9. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein. Chisari FV; Bieber MS; Josepho CA; Xavier C; Anderson DS J Immunol; 1981 Jan; 126(1):45-9. PubMed ID: 6450241 [TBL] [Abstract][Full Text] [Related]
11. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B. Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726 [TBL] [Abstract][Full Text] [Related]
12. Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. Mondelli MU; Bortolotti F; Pontisso P; Rondanelli EG; Williams R; Realdi G; Alberti A; Eddleston AL Clin Exp Immunol; 1987 May; 68(2):242-50. PubMed ID: 3498568 [TBL] [Abstract][Full Text] [Related]
13. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407 [TBL] [Abstract][Full Text] [Related]
14. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease. Mieli-Vergani G; Vergani D; Portmann B; White Y; Murray-Lyon I; Marigold JH; Woolf I; Eddleston AL; Williams R Gut; 1982 Dec; 23(12):1029-36. PubMed ID: 6983473 [TBL] [Abstract][Full Text] [Related]
15. Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis. Ortona L; Laghi V; Cauda R; Nervo P Clin Exp Immunol; 1979 Nov; 38(2):231-4. PubMed ID: 527260 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis. Kakumu S; Hara T; Gohji H; Sakamoto N Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte cytotoxicity for autologous human hepatocytes in alcoholic liver disease. Izumi N; Hasumura Y; Takeuchi J Clin Exp Immunol; 1983 Oct; 54(1):219-24. PubMed ID: 6604608 [TBL] [Abstract][Full Text] [Related]
18. K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease. Kawanishi H; MacDermott RP Gastroenterology; 1979 Jan; 76(1):151-8. PubMed ID: 361492 [TBL] [Abstract][Full Text] [Related]
19. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I. Lymphocyte subpopulations. Ponzetto A; Arrigoni A G Batteriol Virol Immunol; 1979; 72(1-6):28-32. PubMed ID: 317950 [TBL] [Abstract][Full Text] [Related]
20. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus. Barnaba V; Franco A; Paroli M; Benvenuto R; De Petrillo G; Burgio VL; Santilio I; Balsano C; Bonavita MS; Cappelli G J Immunol; 1994 Mar; 152(6):3074-87. PubMed ID: 7511637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]